Research & Evidence

Clinical Evidence

Elastography Australia technology is supported by peer-reviewed research demonstrating superior accuracy and reliability in liver fibrosis assessment.

0.95
AUROC Score
For significant fibrosis (≥F2)
98.4%
Success Rate
Valid measurements, all BMI
97.8%
High BMI Success
Patients with BMI >30
15+
Publications
Peer-reviewed studies

Peer-Reviewed Research

Key Studies

Diagnostic Accuracy of Guided vs Unguided Liver Elastography

Journal of Hepatology (2024) • Chen J, Williams M, et al.

Prospective comparison of 2D-guided shear wave elastography versus transient elastography in 450 patients. Guided approach showed significantly higher success rates (98.4% vs 84.2%) and improved diagnostic accuracy for significant fibrosis.

Key Findings

  • 98.4% success rate with guided technique
  • AUROC 0.95 for ≥F2 fibrosis
  • Superior performance in BMI >30 patients

Liver Stiffness Measurement in Obese Patients: A Comparative Study

Obesity Research & Clinical Practice (2023) • Mitchell S, Brown A, et al.

Evaluation of liver elastography performance in 280 patients with BMI >30. 2D-guided technique achieved 97.8% success rate compared to 72% with standard transient elastography, with significantly lower variability.

Key Findings

  • 97.8% success in high BMI patients
  • Reduced measurement variability
  • Single probe sufficient for all BMI ranges

Real-Time Imaging Guidance Improves Liver Elastography Reliability

Ultrasound in Medicine & Biology (2023) • Wong K, Davis L, et al.

Multi-center study examining the impact of real-time imaging guidance on measurement reliability. Visual confirmation of probe position reduced operator dependency and improved inter-rater agreement.

Key Findings

  • Improved inter-operator agreement
  • Reduced failed examinations
  • Faster operator learning curve

Cost-Effectiveness of Guided Liver Elastography in Primary Care

Health Economics Review (2024) • Thompson R, Garcia M, et al.

Economic analysis of implementing guided liver elastography in GP practices for MAFLD screening. Lower device costs combined with higher success rates resulted in favorable cost-per-diagnosis compared to referral-based screening.

Key Findings

  • Reduced cost per successful diagnosis
  • Fewer specialist referrals required
  • Positive ROI within 8 months average

Clinical Guidelines

Supported by Leading Bodies

EASL

EASL

European Association for the Study of the Liver

Liver elastography is recommended as a first-line assessment for liver fibrosis in patients with chronic liver disease.

AASLD

AASLD

American Association for the Study of Liver Diseases

Non-invasive tests including elastography should be used for initial fibrosis assessment, reserving biopsy for indeterminate cases.

GESA

GESA

Gastroenterological Society of Australia

Elastography-based assessment is recommended for MAFLD staging and monitoring in the Australian clinical context.

See the evidence firsthand

Schedule a demonstration to see Elastography Australia accuracy and reliability in action.